Colorectal Cancer Clinical Trial
— PREPCOLONOfficial title:
Design of a Mobile Application to Improve the Quality of Colonoscopy and Its Implementation in Colorectal Cancer Screening Program: a Randomized Multicenter Study (PrepColon APP Study)
Colonoscopy is the gold standard for the diagnosis and resection of preneoplastic lesions, allowing the prevention of colon cancer. A colonoscopy is more efficient with proper preparation of the colon, as it allows for a higher rate of adenoma detection and cecal intubation. In routine practice, up to 30% of colonoscopies are poorly prepared and 11% of patients do not show up for their appointment. Adenomas not visualized in the initial colonoscopy due to poor preparation reached 68% and the rate of undetected cancers was 66.7%. A proper colon cleanse is conditioned by different factors; among them, failure to comply with the diet and take laxatives poses 5 times the risk of having a deficient colon preparation. The purpose of our study is the design and implementation of an app that facilitates the preparation of colonoscopy and evaluates its impact on compliance with diet and laxative intake.
Status | Not yet recruiting |
Enrollment | 470 |
Est. completion date | December 30, 2025 |
Est. primary completion date | December 30, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 69 Years |
Eligibility | Inclusion Criteria: - -Subjects between 50-69 years old from the CRC screening program with FIT (>100ng/ml). - Informed consent granted in writing Exclusion Criteria: - Refusal to give informed consent. - Those who do not have a smartphone with a minimum version of the operating system (Android 4.4 or iOS 14, which cover more than 99% of the terminals in use) - Symptomatic patients - Subjects at elevated risk of CRC due to family history or inherited polyposis diseases or inflammatory bowel disease |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Universitario Rio Hortega | Valladolid |
Lead Sponsor | Collaborator |
---|---|
Hospital del Río Hortega |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compliance with the diet and intake of laxatives with the use of a mobile application | Questionnaire about ASSESSMENT OF DIET COMPLIANCE (number of portions 0->2, higher points means worse outcome):
Have you followed the diet without fiber the 3 days prior to preparation: YES/ NO Have you eaten fruits, vegetables and legumes? number of portions 0 1 2 >2 Have you eaten whole grain products? number of portions 0 1 2 >2 Have you eaten meats and sausages? number of portions 0 1 2 >2 Have you eaten blue fish? number of portions 0 1 2 >2 Have you eaten nuts? number of portions 0 1 2 >2 Have you eaten anything solid in the last 24 hours? yes/ no |
at the moment of the procedure | |
Primary | Evaluate the quality of colon cleansing with mobile application as an experimental factor | The endoscopy will assess colon cleansing according to the Boston Bowel Scale (BBPS) uses a 4-point rating system (0-3) applied to each of the 3 segments of the colon (right, transverse, left) to assess colon cleanliness during the withdrawal phase of colonoscopy, after all cleaning maneuvers have been performed. (0 worse outcome and 3 best outcome) | at the moment of the procedure | |
Primary | Assessment of the usability of the APP | A questionare: System Usability scale (SUS), ten question about usability with Five responses ranging from Strongly Agree to Strongly Disagree | at the moment of the procedure | |
Primary | Compliance with the laxative intake with the use of the mobile application | Questionnaire to EVALUATE COMPLIANCE WITH TAKING THE LAXATIVE: questions like at • --Type of laxative: (name):
Colonoscopy appointment (time) Morning / Afternoon Start of taking the laxative: time: End of taking the laxative (How many hours ago did you finish taking the laxative before the appointment? Have you taken all of the laxative? How much liquid have you drunk? How many shots have you done it in? How much liquid does each drink? |
At the moment of the procedure | |
Secondary | Assessment of the difficulty of the preparation instructions | quesionnaire: EVALUATION OF THE COMPRESSION OF THE INSTRUCTIONS GIVEN: scale from 0 to 10 (0:worse outcomes and 10: best outcomes) | at the moment of the procedure | |
Secondary | Evaluate colonoscopy quality indicators: | Adenoma detection rate (ADR) is the percentage of patients with at least one histologically proven adenoma or carcinoma | at the moment of the procedure and after one month with the histological results | |
Secondary | Evaluate attendance at the scheduled colonoscopy appointment | Attendance or not to colonoscopy appointment | at the moment of the colonoscopy | |
Secondary | Evaluate colonoscopy quality indicators | Cecal intubation rate is the percentage of patients with completed colonoscopy | at the moment of the colonoscopy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |